Lai, Y. 2023. Sodium Channel Inhibitors (Nav1.7, 1.8, And 1.9) For Neuropathic Pain Management. Highlights in Science, Engineering and Technology. 74, (Dec. 2023), 1085–1095. DOI:https://doi.org/10.54097/wghqc383.